Literature DB >> 16824017

Telomeres: cancer to human aging.

Sheila A Stewart1, Robert A Weinberg.   

Abstract

The cell phenotypes of senescence and crisis operate to circumscribe the proliferative potential of mammalian cells, suggesting that both are capable of operating in vivo to suppress the formation of tumors. The key regulators of these phenotypes are the telomeres, which are located at the ends of chromosomes and operate to protect the chromosomes from end-to-end fusions. Telomere erosion below a certain length can trigger crisis. The relationship between senescence and telomere function is more complex, however: Cell-physiological stresses as well as dysfunction of the complex molecular structures at the ends of telomeric DNA can trigger senescence. Cells can escape senescence by inactivating the Rb and p53 tumor suppressor proteins and can surmount crisis by activating a telomere maintenance mechanism. The resulting cell immortalization is an essential component of the tumorigenic phenotype of human cancer cells. Here we discuss how telomeres are monitored and maintained and how loss of a functional telomere influences biological functions as diverse as aging and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824017     DOI: 10.1146/annurev.cellbio.22.010305.104518

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  124 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Separation of telomerase functions by reverse genetics.

Authors:  Shibani Mukherjee; Eduardo J Firpo; Yang Wang; James M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

3.  Maintenance of very long telomeres by recombination in the Kluyveromyces lactis stn1-M1 mutant involves extreme telomeric turnover, telomeric circles, and concerted telomeric amplification.

Authors:  Jianing Xu; Michael J McEachern
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

4.  Establishment and characterization of fibroblast cell lines from the skin of the Yangtze finless porpoise.

Authors:  Jingzhen Wang; Weiting Su; Wenhui Nie; Jinhuan Wang; Wuhan Xiao; Ding Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-30       Impact factor: 2.416

5.  Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: Findings from the Singapore Chinese Health Study.

Authors:  Jian-Min Yuan; Kenneth B Beckman; Renwei Wang; Caroline Bull; Jennifer Adams-Haduch; Joyce Y Huang; Aizhen Jin; Patricia Opresko; Anne B Newman; Yun-Ling Zheng; Michael Fenech; Woon-Puay Koh
Journal:  Int J Cancer       Date:  2018-01-25       Impact factor: 7.396

6.  Telomere length and cancer mortality in American Indians: the Strong Heart Study.

Authors:  Pooja Subedi; Stefano Nembrini; Qiang An; Yun Zhu; Hao Peng; Fawn Yeh; Shelley A Cole; Dorothy A Rhoades; Elisa T Lee; Jinying Zhao
Journal:  Geroscience       Date:  2019-06-22       Impact factor: 7.713

7.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

Review 8.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  A prospective study of relative telomere length and postmenopausal breast cancer risk.

Authors:  Immaculata De Vivo; Jennifer Prescott; Jason Y Y Wong; Peter Kraft; Susan E Hankinson; David J Hunter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

10.  G-quadruplex nucleic acids as therapeutic targets.

Authors:  Shankar Balasubramanian; Stephen Neidle
Journal:  Curr Opin Chem Biol       Date:  2009-06-08       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.